The Imperative to Enhance Cost-Effectiveness for Cardiovascular Therapeutic Development-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Imperative to Enhance Cost-Effectiveness for Cardiovascular Therapeutic Development

Published:2024-08 Issue:8 Volume:9 Page:1029-1040
ISSN:2452-302X
Container-title:JACC: Basic to Translational Science
language:en
Short-container-title:JACC: Basic to Translational Science

Author:

Davidson Michael H.,Hsieh Andrew^ORCID,Dicklin Mary R.,Maki Kevin C.

Publisher

Elsevier BV

Reference78 articles.

1. Provisional mortality data—United States, 2022;Ahmad;MMWR Morb Mortal Wkly Rep,2023

2. A historical perspective on the discovery of statins;Endo;Proc Jpn Acad Ser B Phys Biol Sci,2010

3. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines;Arnett;J Am Coll Cardiol,2019

4. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines;Virani;J Am Coll Cardiol,2023

5. Device therapy in chronic heart failure: JACC state-of-the-art review;Fudim;J Am Coll Cardiol,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP